Physician profile
Jack C Choi
NPI 1902840382
$2,333.16
in general payments reported to CMS, 2019-2025
14 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $235 · 2021: $625 · 2022: $1,030 · 2023: $95.40 · 2024: $61.43 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $95.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $95.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,713.52 | 2019-2023 | |
| Amgen INC. | $102.60 | 2019-2025 | Repatha, Evenity |
| Astrazeneca Pharmaceuticals LP | $90.40 | 2020-2025 | Airsupra, Breztri |
| Horizon Therapeutics Plc | $81.63 | 2019-2022 | |
| Novo Nordisk INC | $76.65 | 2019-2025 | Wegovy |
| Abbvie INC. | $60.13 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.42 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $49.06 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $28.22 | 2025 | Zoryve |
| Abbott Laboratories | $22.94 | 2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $15.93 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.68 | 2024 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $13.46 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.